950 related articles for article (PubMed ID: 2164926)
1. Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo.
Reinhardt TA; Horst RL
Endocrinology; 1990 Aug; 127(2):942-8. PubMed ID: 2164926
[TBL] [Abstract][Full Text] [Related]
2. Interaction between calcium and 1,25-dihydroxyvitamin D3 in the regulation of preproparathyroid hormone and vitamin D receptor messenger ribonucleic acid in avian parathyroids.
Russell J; Bar A; Sherwood LM; Hurwitz S
Endocrinology; 1993 Jun; 132(6):2639-44. PubMed ID: 8389284
[TBL] [Abstract][Full Text] [Related]
3. Regulation of intestinal vitamin D receptor expression in experimental uraemia: effects of parathyroidectomy and administration of PTH.
Szabó A; Schmutz A; Pesian S; Schmidt-Gayk H; Ritz E; Reichel H
Nephrol Dial Transplant; 1998 Feb; 13(2):340-9. PubMed ID: 9509444
[TBL] [Abstract][Full Text] [Related]
4. Evidence for coordinated regulation of osteoblast function by 1,25-dihydroxyvitamin D3 and parathyroid hormone.
van Leeuwen JP; Birkenhäger JC; van den Bemd GC; Pols HA
Biochim Biophys Acta; 1996 Jun; 1312(1):54-62. PubMed ID: 8679716
[TBL] [Abstract][Full Text] [Related]
5. The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells.
Pernalete N; Mori T; Nishii Y; Slatopolsky E; Brown AJ
Endocrinology; 1991 Aug; 129(2):778-84. PubMed ID: 1649745
[TBL] [Abstract][Full Text] [Related]
6. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands.
Brown AJ; Zhong M; Finch J; Ritter C; Slatopolsky E
Endocrinology; 1995 Apr; 136(4):1419-25. PubMed ID: 7895652
[TBL] [Abstract][Full Text] [Related]
7. Regulation of renal parathyroid hormone receptor expression by 1, 25-dihydroxyvitamin D3 and retinoic acid.
Sneddon WB; Barry EL; Coutermarsh BA; Gesek FA; Liu F; Friedman PA
Cell Physiol Biochem; 1998; 8(5):261-77. PubMed ID: 9792954
[TBL] [Abstract][Full Text] [Related]
8. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
Chow EC; Quach HP; Vieth R; Pang KS
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
[TBL] [Abstract][Full Text] [Related]
9. Homologous up-regulation of vitamin D receptors is tissue specific in the rat.
Gensure RC; Antrobus SD; Fox J; Okwueze M; Talton SY; Walters MR
J Bone Miner Res; 1998 Mar; 13(3):454-63. PubMed ID: 9525346
[TBL] [Abstract][Full Text] [Related]
10. Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by parathyroid hormone and cAMP-agonists.
van Leeuwen JP; Birkenhäger JC; Vink-van Wijngaarden T; van den Bemd GJ; Pols HA
Biochem Biophys Res Commun; 1992 Jun; 185(3):881-6. PubMed ID: 1320878
[TBL] [Abstract][Full Text] [Related]
11. Abnormal expression and regulation of vitamin D receptor in experimental uremia.
Szabó A; Ritz E; Schmidt-Gayk H; Reichel H
Nephron; 1996; 73(4):619-28. PubMed ID: 8856261
[TBL] [Abstract][Full Text] [Related]
12. Structure-function relationship of human parathyroid hormone in the regulation of vitamin D receptor expression in osteoblast-like cells (ROS 17/2.8).
Sriussadaporn S; Wong MS; Whitfield JF; Tembe V; Favus MJ
Endocrinology; 1995 Sep; 136(9):3735-42. PubMed ID: 7649079
[TBL] [Abstract][Full Text] [Related]
13. Regulation of messenger ribonucleic acid expression of 1 alpha,25-dihydroxyvitamin D3-24-hydroxylase in rat osteoblasts.
Nishimura A; Shinki T; Jin CH; Ohyama Y; Noshiro M; Okuda K; Suda T
Endocrinology; 1994 Apr; 134(4):1794-9. PubMed ID: 8137744
[TBL] [Abstract][Full Text] [Related]
14. Influence of aluminum on the regulation of PTH- and 1,25(OH)2D3-dependent pathways in the rat osteosarcoma cell line ROS 17/2.8.
Lajeunesse D; Moreau R; Hobbs W; Qui W; Lafond J; Guggino SE
J Bone Miner Res; 1998 Jun; 13(6):962-9. PubMed ID: 9626627
[TBL] [Abstract][Full Text] [Related]
15. Evidence that estrogens modulate activity and increase the number of 1,25-dihydroxyvitamin D receptors in osteoblast-like cells (ROS 17/2.8).
Liel Y; Kraus S; Levy J; Shany S
Endocrinology; 1992 May; 130(5):2597-601. PubMed ID: 1315250
[TBL] [Abstract][Full Text] [Related]
16. Modulation by retinoic acid of 1,25-dihydroxyvitamin D3 effects on alkaline phosphatase activity and parathyroid hormone responsiveness in an osteoblast-like osteosarcoma cell line.
Grigoriadis AE; Petkovich PM; Rosenthal EE; Heersche JN
Endocrinology; 1986 Aug; 119(2):932-9. PubMed ID: 3015560
[TBL] [Abstract][Full Text] [Related]
17. Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by 1,25-dihydroxyvitamin D3 in the parathyroid in vivo.
Naveh-Many T; Marx R; Keshet E; Pike JW; Silver J
J Clin Invest; 1990 Dec; 86(6):1968-75. PubMed ID: 2174913
[TBL] [Abstract][Full Text] [Related]
18. Regulation of 1,25-dihydroxyvitamin D3 receptors by parathyroid hormone in osteoblastic cells: role of second messenger pathways.
Krishnan AV; Cramer SD; Bringhurst FR; Feldman D
Endocrinology; 1995 Feb; 136(2):705-12. PubMed ID: 7835303
[TBL] [Abstract][Full Text] [Related]
19. Effect of glucocorticoids and 1,25-dihydroxyvitamin D3 on the developmental expression of the rat intestinal vitamin D receptor gene.
Lee S; Szlachetka M; Christakos S
Endocrinology; 1991 Jul; 129(1):396-401. PubMed ID: 1647304
[TBL] [Abstract][Full Text] [Related]
20. Hyperresponsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone-forming rats.
Yao J; Kathpalia P; Bushinsky DA; Favus MJ
J Clin Invest; 1998 May; 101(10):2223-32. PubMed ID: 9593778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
